Search clinical trials for: Discontinue Clopidogrel

Total 863 results

Hopital du Sacre-Coeur de Montreal

Completed

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

Coronary Artery Disease

Canada
Sanofi
Bristol-Myers Squibb

Completed

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

Ischemia
R&D Cardiologie

Completed

Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery (IMPACT)

Carotid Stenosis

Netherlands
University of Cologne

Completed

Effects of Clopidogrel on Blood Pressure

Blood Pressure | Endothelial Function | Platelet Function

Germany, Netherlands
Shenyang Northern Hospital

Completed

Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation

Acute Coronary Syndrome
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

United States, Canada, Australia, Puerto Rico
Universitätsklinikum Hamburg-Eppendorf

Terminated

Ziprasidone and Sertraline in PTSD

Post-traumatic Stress Disorder

Germany
Pamukkale University

Completed

Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo

Nausea | Vomiting | Vertigo
Asan Medical Center

Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent (OPTIMIZE-APT)

Coronary Artery Disease

Korea, Republic of
Guangdong Provincial People's Hospital

Recruiting

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine (SPRING)

Migraine | PFO - Patent Foramen Ovale

China
Science Valley Research Institute
Wyeth is now a wholly owned subsidiary of Pfizer

Recruiting

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. (AGRIPPA)

Critical Limb Ischemia

Brazil
Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Completed

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Stroke | Transient Ischemic Attack

China
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Second Affiliated Hospital, School of Medicine,...

Unknown

DUAL Antithrombotic Therapy in Patients With AF and ACS

Atrial Fibrillation | Acute Coronary Syndromes
C. Clay Cothren, MD

Withdrawn

Anticoagulation in Blunt Cerebrovascular Injuries

Carotid Artery Injury | Vertebral Artery Injury

United States
Beijing Anzhen Hospital

Unknown

Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Atrial Fibrillation

China
Ronald Hoffman
National Cancer Institute (NCI); Myeloproliferative Disorders-Research Consortium

Withdrawn

Clopidogrel and Aspirin for the Treatment of Polycythemia Vera (ISCLAP)

Polycythemia Vera
Rigshospitalet, Denmark

Unknown

ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery (TEG-CABG)

Thrombosis | Coronary Artery Bypass Grafting Surgery | Hypercoagulability | Graft Patency

Denmark
Inje University

Completed

The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

Interaction
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb; Sanofi; Institut National de la Santé Et de la Recherche... and other collaborators

Completed

Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy (ARCTIC)

Coronary Artery Disease | Acute Coronary Syndrome

France
Asan Medical Center
Takeda

Unknown

Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?

Early Gastric Cancer | Gastric Dysplasia

Korea, Republic of
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Yonsei University

Terminated

Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Acute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina (Intermediate Coronary Syndrome)

Korea, Republic of
Kiyuk Chang
AstraZeneca

Unknown

Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation

Endothelial Dysfunction | Vascular Inflammation

Korea, Republic of
Chinese PLA General Hospital

Unknown

Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction

Cardiovascular Diseases

China
AstraZeneca

Completed

Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

Acute Coronary Syndrome

United States
Inha University Hospital

Completed

Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction

ST Segment Elevation Myocardial Infarction | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
Campus Bio-Medico University

Unknown

Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy

Myocardial Infarction | Acute Coronary Syndrome

Italy
Assistance Publique Hopitaux De Marseille

Recruiting

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. (TROUPER)

Acute Coronary Syndrome

France
University Hospitals Cleveland Medical Center

Completed

Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)

Inflammation | Thrombosis | Aortic Stenosis

United States
Madrigal Pharmaceuticals, Inc.

Completed

Drug Interaction Study of MGL-3196 With Clopidogrel

Healthy

United States
Laboratoires Teriak

Completed

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg (IDASCOP 1)

Diabetes Mellitus, Type 2 | Coronary Angioplasty | NSTEMI - Non-ST Segment Elevation MI

Tunisia
Akcea Therapeutics

Completed

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Cardiovascular Diseases | Elevated Lipoprotein(a)

Canada
Dong-A University
AstraZeneca; Biotronik SE & Co. KG

Completed

Comparing Ticagrelor Versus Clopidogrel on Microcirculation (PLEIO)

Acute Coronary Syndrome

Korea, Republic of
University of Patras
AstraZeneca

Completed

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction (ALTIC)

Myocardial Infarction | Coronary Artery Disease | Diabetes Mellitus | Renal Disease

Greece
Taipei Veterans General Hospital, Taiwan

Unknown

Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

Acute Coronary Syndrome

Taiwan
CHEOL WHAN LEE, M.D., Ph.D
AstraZeneca; CardioVascular Research Foundation, Korea

Completed

Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation

Plaque, Atherosclerotic

Korea, Republic of
Centre Hospitalier Universitaire de Saint Etienne
Groupe de Recherche sur la Thrombose

Completed

Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke (AAPIX)

Brain Ischemia | Ischemic Attack

France
AstraZeneca

Completed

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Stable Coronary Artery Disease

United States
Novartis

Completed

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Osteoporosis

United States, Belgium, Germany, Spain
Assistance Publique Hopitaux De Marseille

Completed

Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

Acute Coronary Syndrome

France
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions

Healthy

Canada
Catharina Ziekenhuis Eindhoven

Completed

Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.

Coronary Artery Disease
Kafrelsheikh University

Recruiting

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

Ischemic Stroke

Egypt
Ahmad Slim
Bristol-Myers Squibb

Terminated

Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)

Coronary Graft Patency

United States
US Department of Veterans Affairs
Bristol-Myers Squibb; Sanofi-Synthelabo

Completed

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Heart Failure

United States, Canada, United Kingdom
Kafrelsheikh University

Recruiting

Clopidogrel Versus Cilostazol in Ischemic Stroke

Ischemic Stroke

Egypt
Peking Union Medical College Hospital
Pharmaron (Chengdu) Clinical Services Co., Ltd.

Recruiting

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) (BRANT)

Branch Atheromatous Disease

China
Samsung Medical Center

Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold (SMART-CHOICEII)

Coronary Artery Disease | Atherosclerosis | Stents

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Completed

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Coronary Heart Disease

China

Search clinical trials for: Discontinue Clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations